In a first for adults in Singapore, scientists are conducting gene editing trials on heart patients to correct defects at ...

What scientific knowledge is and is not presumed in legal reasoning, and what are the differences between what is and what is ...

Seven years after the first gene-edited babies were revealed, biotech startup Manhattan Genomics is reviving the idea of ...

A lthough still in its early days, CRISPR has already been called the most powerful scientific tool of the century. Using ...

Intellia Therapeutics, Inc. is rated Hold due to uncertainty from dosing pause in its MAGNITUDE program for ATTR. Learn more ...

According to Nova One Advisor, the global genomics data analysis market size is calculated at USD 7.91 billion in 2025 and is ...

A researcher at the University of Houston finds management of diabetic ketoacidosis may center around reducing ketone levels ...

Two days after Intellia voluntarily paused dosing due to safety concerns, the regulator stepped in with an official hold that makes a longer halt more likely.

DELRAY BEACH, Fla., Oct. 31, 2025 /PRNewswire/ — According to MarketsandMarkets™, The agriculture biotechnology market is ...

Washington University researchers discovered how yellow fever and tick-borne encephalitis viruses enter human cells and ...

Professor David Williams, a New Zealander working on gene therapy at UCLA, has warned that the Bill is “unfair to farmers” and based on false assumptions about precision and safety. He points to ...